Eris Lifesciences has informed that an allotment of 22,492 equity shares has been made on June 20, 2024, pursuant to exercise of options under the ESOP Schemes. Further details are enclosed. The paid-up share capital of the Company accordingly stands increased from Rs 13,60,52,516/- (13,60,52,516 equity shares of Re 1/- each) to Rs 13,60,75,008 (13,60,75,008 equity shares of Re.1/- each).
The above information is a part of company’s filings submitted to BSE.